Dare Bioscience, Inc.
DARENasdaqCIK 1401914HealthcareFiscal year ends Dec 31
Reports and events: 319 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0617:00 ET | DEF 14A | Proxy statementPeriod 2026-10-06 | 0001493152-26-045977 |
| 2026-10-0216:01 ET | 8-K | 3.01 Delisting notice | 0001401914-26-000052 |
| 2026-10-0109:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-045275 |
| 2026-09-1116:29 ET | 8-K | 5.03 Amendment to articles or bylaws | 0001401914-26-000050 |
| 2026-09-0909:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-041904 |
| 2026-08-2617:15 ET | S-1 | Registration statement | 0001493152-26-040265 |
| 2026-08-1708:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-038649 |
| 2026-08-1316:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037737 |
| 2026-08-1316:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001401914-26-000043 |
| 2026-07-2409:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-034483 |
| 2026-07-1716:07 ET | 8-K | 3.01 Delisting notice | 0001401914-26-000040 |
| 2026-07-1309:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-032963 |
| 2026-06-2209:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-029515 |
| 2026-06-1216:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001401914-26-000032 |
| 2026-05-1816:25 ET | 8-K | 3.02 Unregistered sale of equity | 0001401914-26-000030 |
| 2026-05-1416:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001401914-26-000026 |
| 2026-05-1416:01 ET | 8-K | 2.02 Results of operations | 0001401914-26-000025 |
| 2026-05-0716:11 ET | 8-K | 3.02 Unregistered sale of equity | 0001401914-26-000021 |
| 2026-04-2816:02 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001401914-26-000014 |
| 2026-04-2209:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-018460 |
| 2026-04-2016:07 ET | 8-K | 3.02 Unregistered sale of equity | 0001401914-26-000012 |
| 2026-04-1716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001401914-26-000010 |
| 2026-04-1316:58 ET | 8-K | 3.02 Unregistered sale of equity | 0001401914-26-000006 |
| 2026-03-2616:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001401914-26-000004 |
| 2026-03-2616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-012902 |
| 2026-03-1716:37 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-26-010594 |
| 2026-03-0916:05 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-26-009364 |
| 2026-03-0208:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008451 |
| 2026-01-2917:00 ET | 8-K | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-004245 |
| 2026-01-0608:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-000513 |
| 2025-12-0108:01 ET | 8-K | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025491 |
| 2025-11-1316:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001401914-25-000050 |
| 2025-11-1316:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022277 |
| 2025-09-0208:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-012516 |
| 2025-08-1416:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001401914-25-000044 |
| 2025-08-1416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023971 |
| 2025-07-2508:00 ET | 8-K | 8.01 Other events | 0001493152-25-011402 |
| 2025-07-2117:48 ET | 8-K | 8.01 Other events | 0001641172-25-020295 |
| 2025-07-1408:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-018894 |
| 2025-07-0916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-018393 |
| 2025-06-2508:00 ET | 8-K | 8.01 Other events | 0001641172-25-016374 |
| 2025-06-0908:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-014238 |
| 2025-05-1316:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001401914-25-000022 |
| 2025-05-1316:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009939 |
| 2025-04-2416:02 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001401914-25-000014 |
| 2025-04-1117:15 ET | 8-K | 8.01 Other events | 0001641172-25-003887 |
| 2025-03-3116:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001401914-25-000012 |
| 2025-03-3116:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001682 |
| 2025-02-1417:10 ET | 8-K | 3.01 Delisting notice | 0001493152-25-006958 |
| 2025-02-1008:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-005533 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:00 ET. Listed shows no prices and gives no investment advice.